PK Study of PT003 and PT001 in Japanese Healthy Subjects

NCT02196714 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

COPD

Interventions

DRUG: Glycopyrronium and Formoterol Fumarate (GFF) Dose 1
DRUG: Glycopyrronium and Formoterol Fumarate (GFF) Dose 2
DRUG: Glycopyrronium (GP) Dose 1
DRUG: Glycopyrronium (GP) Dose 2

Sponsor

Pearl Therapeutics, Inc.